What Researchers Did
This systematic review discussed the current understanding of bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) in preterm infants and highlighted potential new ways to predict and treat the condition.
What They Found
The researchers found that bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) affects 17-24% of infants with bronchopulmonary dysplasia (BPD). BPD-PH significantly increases the risk of illness and death, with mortality rates reaching up to 50% in affected infants. Currently, there is no safe and effective treatment for BPD and BPD-PH.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a review, this study synthesizes existing research and does not present new experimental data or clinical trial results.